213 related articles for article (PubMed ID: 9855005)
1. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.
Glaab WE; Risinger JI; Umar A; Barrett JC; Kunkel TA; Tindall KR
Carcinogenesis; 1998 Nov; 19(11):1931-7. PubMed ID: 9855005
[TBL] [Abstract][Full Text] [Related]
2. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.
Glaab WE; Tindall KR
Carcinogenesis; 1997 Jan; 18(1):1-8. PubMed ID: 9054582
[TBL] [Abstract][Full Text] [Related]
3. Suppression of spontaneous and hydrogen peroxide-induced mutagenesis by the antioxidant ascorbate in mismatch repair-deficient human colon cancer cells.
Glaab WE; Hill RB; Skopek TR
Carcinogenesis; 2001 Oct; 22(10):1709-13. PubMed ID: 11577013
[TBL] [Abstract][Full Text] [Related]
4. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
5. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
Yan T; Berry SE; Desai AB; Kinsella TJ
Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
[TBL] [Abstract][Full Text] [Related]
6. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
[TBL] [Abstract][Full Text] [Related]
7. Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines.
Glaab WE; Tindall KR; Skopek TR
Mutat Res; 1999 Jun; 427(2):67-78. PubMed ID: 10393261
[TBL] [Abstract][Full Text] [Related]
8. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
9. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines.
Chang DK; Goel A; Ricciardiello L; Lee DH; Chang CL; Carethers JM; Boland CR
Cancer Lett; 2003 Jun; 195(2):243-51. PubMed ID: 12767533
[TBL] [Abstract][Full Text] [Related]
10. Loss of DNA mismatch repair in acquired resistance to cisplatin.
Aebi S; Kurdi-Haidar B; Gordon R; Cenni B; Zheng H; Fink D; Christen RD; Boland CR; Koi M; Fishel R; Howell SB
Cancer Res; 1996 Jul; 56(13):3087-90. PubMed ID: 8674066
[TBL] [Abstract][Full Text] [Related]
11. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
[TBL] [Abstract][Full Text] [Related]
12. Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance.
de las Alas MM; Aebi S; Fink D; Howell SB; Los G
J Natl Cancer Inst; 1997 Oct; 89(20):1537-41. PubMed ID: 9337351
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced O(6)-benzylguanine-resistant alkyltransferase mutations in mismatch-deficient colon cancer.
Liu L; Schwartz S; Davis BM; Gerson SL
Cancer Res; 2002 Jun; 62(11):3070-6. PubMed ID: 12036916
[TBL] [Abstract][Full Text] [Related]
14. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
[TBL] [Abstract][Full Text] [Related]
15. Cellular resistance and hypermutability in mismatch repair-deficient human cancer cell lines following treatment with methyl methanesulfonate.
Glaab WE; Risinger JI; Umar A; Barrett JC; Kunkel TA; Tindall KR
Mutat Res; 1998 Feb; 398(1-2):197-207. PubMed ID: 9626980
[TBL] [Abstract][Full Text] [Related]
16. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
17. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells.
Aebi S; Fink D; Gordon R; Kim HK; Zheng H; Fink JL; Howell SB
Clin Cancer Res; 1997 Oct; 3(10):1763-7. PubMed ID: 9815561
[TBL] [Abstract][Full Text] [Related]
18. Modulation of drug resistance mediated by loss of mismatch repair by the DNA polymerase inhibitor aphidicolin.
Moreland NJ; Illand M; Kim YT; Paul J; Brown R
Cancer Res; 1999 May; 59(9):2102-6. PubMed ID: 10232595
[TBL] [Abstract][Full Text] [Related]
19. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
[TBL] [Abstract][Full Text] [Related]
20. Basis for differential cellular sensitivity to 8-azaguanine and 6-thioguanine.
van Diggelen OP; Donahue TF; Shin SI
J Cell Physiol; 1979 Jan; 98(1):59-71. PubMed ID: 762202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
